Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01756573 · ClinicalTrials.gov registry record · NA
Dexamethasone and Block Duration in Upper Extremity
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01756573 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 5 participants.
The verdict
NCT01756573, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Effect of dexamethasone on prolonging upper extremity block is well known. But it not known if the effect comes from its local effect on the nerves or from its general analgesic effect. In this study we will compare the systemic effect to its local effect to find out if there is a difference or not.
Interventions
- DRUG Bupivacaine
- DRUG Dexamthsone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01756573
The ClinicalTrials.gov registry entry for NCT01756573 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT01756573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01756573 about?
NCT01756573 is a clinical study titled "Dexamethasone and Block Duration in Upper Extremity". Effect of dexamethasone on prolonging upper extremity block is well known. But it not known if the effect comes from its local effect on the nerves or from its general analgesic effect. In this study we will compare the systemic effect to its local effect to find out if there is a difference or not.
What is the current status of trial NCT01756573?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2013-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01756573?
The interventions under investigation include: Bupivacaine (DRUG), Dexamthsone (DRUG).
Who is sponsoring clinical trial NCT01756573?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.